CURRENT TRENDS IN PHARMACOLOGICAL TREATMENT OF TYPE 2 DIABETES MELLITUS IN TERTIARY CARE CENTRE IN BUNDELKHAND REGION

Author:

Ratmale Rajni1,Kaushik Sadhna2,Agarwal Mandavi3,Goel Mani1,Singh Hari Naryan1,Singh Vinay Kumar1

Affiliation:

1. Department Of Pharmacology, M.L.B. Medical College, Jhansi, U.P.

2. Department Of Pharmacology, M.L.B. Medical College, Jhansi, U.P

3. Department Of Medicine, M.L.B. Medical College, Jhansi, U.P

Abstract

Introduction: Type 2 diabetes mellitus (DM) is a chronic metabolic condition with an increasing global prevalence. Because of this tendency, it is rapidly becoming an epidemic in some nations, with the number of affected anticipated to quadruple in the next decade as the population ages. The present study aimed to determine the prescribing pattern and adverse drug reaction of different groups of antidiabetic drug in type 2 Diabetes mellitus. Methodology: The present study was an analytical cross-sectional study conducted on total 430 type II diabetes mellitus patients attending OPD in diabetes clinic at M.L.B Medical College, Jhansi during the study period. Various scoring system including WHO causality assessment scale, CDSCO ADR, WHO-UMC Scale, Naranjo algorithm scale were used for assessment. Results: Majority of patients were male [n=248(57.67%) followed by female [n=182(42.33%], respectively. Signicant patients were of middle class [n=201(46.74%) followed by low class [n=139(32.32%] and High class [n=90(20.93%) (P<0.0001*). ADRs reported hypoglycemia was the commonest followed by dyspepsia and epigastric pain and heart burn common. Majority of patients had HbA1c between 7.0-8.0 which is in fair control 37.67% followed by 8.0-10.0 which is unsatisfactory 35.81% and above 10 which is in poor control 18.14% respectively. Signicant Correlation between Medicine with ADR (p=0.0429), Total Cholesterol (p=0.0396*) and Triglycerides (p= 0.0167*). Conclusion: According to causality assessments, majority of patients had possible causalities. Therefore, we may say that present study results provide insight to the healthcare providers on the importance of monitoring and reporting ADR associated with the drugs.

Publisher

World Wide Journals

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3